Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis
Authors
Keywords
Ascites, Hepatic Encephalopathy, Rifaximin, Infections, Machine Learning
Journal
GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-04-21
DOI
10.1053/j.gastro.2021.04.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The use of Rifaximin in Patients with Cirrhosis
- (2021) Paolo Caraceni et al. HEPATOLOGY
- Apparent nosocomial adaptation of Enterococcus faecalis predates the modern hospital era
- (2021) Anna K. Pöntinen et al. Nature Communications
- Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
- (2020) Xifan Wang et al. GUT
- BiomMiner: An advanced exploratory microbiome analysis and visualization pipeline
- (2020) Amirhossein Shamsaddini et al. PLoS One
- Translocation of Viable Gut Microbiota to Mesenteric Adipose Drives Formation of Creeping Fat in Humans
- (2020) Connie W.Y. Ha et al. CELL
- ALTERATIONS IN GUT MICROBIOME IN CIRRHOSIS AS ASSESSED BY QUANTITATIVE METAGENOMICS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE AND PROGNOSIS
- (2020) Cristina Solé et al. GASTROENTEROLOGY
- Targeting the gut-liver-immune axis to treat cirrhosis
- (2020) Thomas Henry Tranah et al. GUT
- Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy
- (2020) Jasmohan S Bajaj et al. GUT
- Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses
- (2020) Brigid S. Boland et al. Science Immunology
- Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
- (2020) Jonel Trebicka et al. Nature Reviews Gastroenterology & Hepatology
- Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review
- (2019) S. Saha et al. CLINICAL MICROBIOLOGY AND INFECTION
- Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list
- (2019) Shayon Salehi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis
- (2019) Jasmohan S. Bajaj et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives
- (2019) Livia Gargiullo et al. Frontiers in Microbiology
- VRE in cirrhotic patients
- (2019) Melissa Barger et al. BMC INFECTIOUS DISEASES
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
- (2019) Yi Duan et al. NATURE
- Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
- (2019) Angela Horvath et al. Scientific Reports
- Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis
- (2018) Jasmohan S Bajaj et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients with Cirrhosis
- (2018) Jasmohan S. Bajaj et al. Clinical Gastroenterology and Hepatology
- Liver–Microbiome Axis in Health and Disease
- (2018) Timon E. Adolph et al. TRENDS IN IMMUNOLOGY
- Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
- (2018) Laura Puchter et al. Antimicrobial Resistance and Infection Control
- Association of Kidney Function with Infections by Multidrug-Resistant Organisms: An Electronic Medical Record Analysis
- (2018) Guobin Su et al. Scientific Reports
- Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
- (2018) Javier Fernández et al. JOURNAL OF HEPATOLOGY
- The Pathogenic Potential of a Microbe
- (2017) Arturo Casadevall mSphere
- Diabetes mellitus in patients with cirrhosis: clinical implications and management
- (2016) Laure Elkrief et al. LIVER INTERNATIONAL
- CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database
- (2016) Baofeng Jia et al. NUCLEIC ACIDS RESEARCH
- Antibiotic resistance in the wild: an eco-evolutionary perspective
- (2016) Teppo Hiltunen et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Vancomycin-Resistant Enterococci Colonization Among Dialysis Patients: A Meta-analysis of Prevalence, Risk Factors, and Significance
- (2015) Ioannis M. Zacharioudakis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality
- (2015) Yanfei Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The biology of bacterial peptidoglycans and their impact on host immunity and physiology
- (2014) Richard Wheeler et al. CELLULAR MICROBIOLOGY
- Rifaximin: beyond the traditional antibiotic activity
- (2014) Fiorella Calanni et al. JOURNAL OF ANTIBIOTICS
- Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
- (2014) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Bacterial phylogeny structures soil resistomes across habitats
- (2014) Kevin J. Forsberg et al. NATURE
- Comment on
- (2013) Fiorella Calanni et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Rifaximin in the Treatment of Irritable Bowel Syndrome
- (2013) David J. Farrell JOURNAL OF CLINICAL GASTROENTEROLOGY
- Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy
- (2013) Guy W. Neff et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Altered profile of human gut microbiome is associated with cirrhosis and its complications
- (2013) Jasmohan S. Bajaj et al. JOURNAL OF HEPATOLOGY
- Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
- (2013) Jasmohan S. Bajaj et al. PLoS One
- The human microbiome as a reservoir of antimicrobial resistance
- (2013) John Penders et al. Frontiers in Microbiology
- A metagenome-wide association study of gut microbiota in type 2 diabetes
- (2012) Junjie Qin et al. NATURE
- Linkage of gut microbiome with cognition in hepatic encephalopathy
- (2011) Jasmohan S. Bajaj et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Characterization of fecal microbial communities in patients with liver cirrhosis
- (2011) Yanfei Chen et al. HEPATOLOGY
- Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
- (2011) Erdal Toprak et al. NATURE GENETICS
- Call of the wild: antibiotic resistance genes in natural environments
- (2010) Heather K. Allen et al. NATURE REVIEWS MICROBIOLOGY
- Rifaximin Treatment in Hepatic Encephalopathy
- (2010) Nathan M. Bass et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center Perspective
- (2009) Jasmohan S Bajaj et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The role of antibiotics and antibiotic resistance in nature
- (2009) Rustam I. Aminov ENVIRONMENTAL MICROBIOLOGY
- Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
- (2009) James Robert White et al. PLoS Computational Biology
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
- A microbial symbiosis factor prevents intestinal inflammatory disease
- (2008) Sarkis K. Mazmanian et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started